Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IGF-1 Generation Test in Children With Chronic Kidney Disease
NCT00212758Phase 4Completed
- Sponsor
- Oregon Health & Science University
- Start
- Jan 2005
- Primary completion
- May 2008
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of somatropin in chronic kidney disease (CKD) and growth hormone deficiency (GHD) (2 arms), sponsored by Oregon Health & Science University. Primary endpoint: Change in Amount of Insulin Like Growth Factor (IGF-I) Generated at Day 8. Started Jan 2005; status: completed.
02
Drugs
somatropin
03
Conditions
chronic kidney disease (CKD)growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT00212758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00212758.